Apr, 1 2026, 0 Comments
Adverse Event Monitoring for Biosimilars: Safety Surveillance Explained
Understanding how biosimilar safety is tracked through adverse event monitoring systems, including differences from generic drugs and current global regulatory frameworks.
Read More